MATTHEW SHAVER: Open Payments
NPI 1376272815 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 38 payments from 9 companies in 2025. Trend: 2023 $920 · 2024 $866 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $274 |
| ABBVIE INC. | 5 | $187 |
| GlaxoSmithKline, LLC. | 8 | $174 |
| Amgen Inc. | 6 | $118 |
| Exact Sciences Corporation | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| PFIZER INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
Products named: Ozempic, TRELEGY ELLIPTA, EVENITY, QULIPTA, Cologuard Collection Kit, VRAYLAR, Wegovy, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
